Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme Cannabis Investing News
Perimeter Medical Imaging AI to Present at the 13th Annual LD Micro Main Event Investor Conference Medical Device Investing
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m Psychedelics Investing
BAVENCIO® Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Pharmaceutical Investing
CHMP Recommends the Approvals of RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic® for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis Biotech Investing
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer Pharmaceutical Investing
Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID® with Cipla Biotech Investing
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S. Pharmaceutical Investing
